BREAKING NEWS

BREAKING NEWS

Baby steps to emerging market growth

Now Reading:

Baby steps to emerging market growth

Text size Aa Aa

$11.8 billion is the price Nestle is going to pay for US firm Pfizer’s infant nutrition business . That is about two billion more than the maximum expected by investors.

In Behind Markets we look at the reasons for the high price and the effects it had.

Click on the link above to see the report